Cyprus Seeds Reinforces Its Position as the Island's Premier Scientific Innovation Catalyst at the Doers Summit 2026
Cyprus Seeds successfully concluded its dynamic participation at the recent DOERS Summit in Limassol, firmly reinforcing its unique position as the only scientific innovation catalyst on the island. Drawing a full house across its two headline events, Cyprus Seeds demonstrated its powerful ecosystem reach by bringing together deep-tech startups, scientific entrepreneurs, and high-profile international investors.
Over the course of the Summit, which attracted thousands of people from the deep-tech community across Europe, the Eastern Mediterranean and the Middle East, Cyprus Seeds anchored the deep-tech conversation not only through its own dedicated events but also by contributing valuable insights to various panel discussions throughout the Summit's broader agenda.
Cyprus Seeds curated two packed-out events, designed to bridge the gap between scientific breakthrough and market commercialization:
• Investors’ Hour (Thursday, May 21): Hosted at the Big Dome (Kolla Factory), this inaugural, exclusive session, brought together a curated cohort of 8 research-driven startups and 16 prominent investors, venture funds and corporate ecosystem representatives from Cyprus, Europe and the Diaspora. The high-energy session featured strict 3-minute startup pitches followed by a rapid-fire 2-minute Q&A with experts, connecting top-tier regional talent with critical private capital (VCs and business angels).
• Innovation Showcase ("Demo Day" - Friday, May 22): the fourth iteration of our annual innovation showcase, or “demo day”, featured a packed house of attendees on the second day of the Summit. The event showcased startups and alumni of Cyprus Seeds’ 4th support cycle, accompanied by inspirational talks, a seaside chat and three thematic panel discussions, involving investors, mentors, scientific entrepreneurs and government officials, demonstrating the breadth of inter-sectoral support for Cyprus Seeds’ approach.
For the past seven years, Cyprus Seeds has been at the forefront of supporting the commercialization of scientific research, from the lab to the market and deep-tech innovation in Cyprus. To date, the organization has helped more than 24 academic and research teams transform their intellectual property into viable ventures with global potential, leading to the creation of multiple successful spinoffs and licensing agreements.
Beyond Cyprus Seeds’ alumni, the startups featured at the DOERS Summit also included hand-picked teams from Greece, the UK, Egypt and India, including: Mammocheck Ltd, A.G. FREYIA LABS Ltd, Pitys.ai Ltd (Cyprus/UK), Podisense Ltd, MEDTL Medical Tech., Axioniq, Cluster (Egypt) and Cluix (India).
The Investors' Hour, organized by Cyprus Seeds on the first day of the Doers Summit, drew a distinguished roster of institutional and private capital, demonstrating Cyprus Seeds' capacity to attract global financial eyes to Cypriot innovation. Participating funds and groups included 33 East, Bulba Ventures, Kinisis Ventures, KOS Technology Partners, Uni.Fund, Zubr Capital, ICLUB Global, Keystones Denmark, Eurobank Cyprus, Samsung Ventures, Eleon Capital, and Berytech.
By orchestrating these high-level interactions and contributing more broadly to the Summit's panels and networking opportunities, Cyprus Seeds has once again proved that it is the vital, singular engine driving scientific research out of the laboratory and onto the global corporate stage.
About Cyprus Seeds
Cyprus Seeds is a non-profit organization dedicated to supporting the commercialization of innovative scientific research and deep-tech in Cyprus. Through grants, as well as from pro bono mentoring, entrepreneurial training, and direct networking with regional and international investors, Cyprus Seeds helps academic and research teams transform their technological breakthroughs into impactful, fundable, scalable ventures. As of 2027, Cyprus Seeds will also be supporting early stage deep-tech startups from Cyprus and the Diaspora.
Media Contact
